Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
17.41
+0.15 (0.87%)
At close: Dec 5, 2025, 4:00 PM EST
17.07
-0.34 (-1.95%)
After-hours: Dec 5, 2025, 7:48 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Novel Small Molecule Precision Medicines
75.62M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
75.62M